Genetically determined reduction in antioxidative protection and increased risk of ischemic heart disease--secondary publication
Juul, K.; Tybjaerg-Hansen, A.; Marklund, S.; Heegaard, N.H.H.; Steffensen, R.; Sillesen, H.H.; Jensen, G.B.; Nordestgaard, Børge.Grønne.
Ugeskrift for Laeger 167(7): 767-770
2005
ISSN/ISBN: 0041-5782 PMID: 15779264 Document Number: 591894
Document emailed within 1 workday
Related Documents
Godtfredsen, N.S.; Prescott, E.; Osler, M. 2006: Smoking reduction is associated with a reduced the risk of lung cancer--a secondary publication Ugeskrift for Laeger 168(7): 695-697Christersen, B. 1995: The effect of general practitioners' advice to men with increased risk of ischemic heart disease Ugeskrift for Laeger 157(30): 4244-4248
Jensen, J.S.; Feldt-Rasmussen, B.F.; Strandgaard, S.; Schroll, M.; Borch-Johnsen, K. 2002: Microalbuminuria is associated with a fourfold increased risk of ischemic heart disease among hypertensive patients Ugeskrift for Laeger 164(32): 3773-3777
Wichmann, T.; Freye, H.A.; Meyer, E.; Teichmann, W.; Schmerling, S. 1982: Lipid chemical parameters and incidence of genetically determined hyperlipoproteinemias in patients between 20 and 45 years of age with coronary heart disease Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 37(12): 379-383
Kalinina, A.M.; Chazova, L.V.; Perova, N.V.; Pavlova, L.I.; Shchepkin, V.V. 1993: An increased risk of death from ischemic heart disease in men with low blood concentrations of total cholesterol and low-density lipoprotein cholesterol Terapevticheskii Arkhiv 65(4): 27-32
2007: Intervention with clarithromycin in patients with stable coronary heart disease--the CLARICOR trial: secondary publication Ugeskrift for Laeger 169(6): 497-499
Mańka-Gaca, I.; Łabuz-Roszak, B.; Machowska-Majchrzak, A. 2018: Genetically determined abnormal electrical activity of the brain and the heart Wiadomosci Lekarskie 71(2 Part 2): 413-416
Stewart, S.H. 2002: Alcohol and inflammation: a possible mechanism for protection against ischemic heart disease Nutrition Metabolism and Cardiovascular Diseases: Nmcd 12(3): 148-151
Rath, R.; Urban, J.; Bláhová, E. 1985: Reduction of the calcium level in bones in ischemic heart disease Vnitrni Lekarstvi 31(3): 270-275
Follath, F. 2001: Ischemic versus non-ischemic heart failure: should the etiology be determined? Heart Failure Monitor 1(4): 122-125
Kuz'ko, N.V. 1979: Increased effectiveness of primary prophylaxis of ischemic heart disease in the polyclinic Vrachebnoe Delo 6: 12-17
Haghfelt, T.H. 1999: Secondary prevention of patients with documented ischemic heart disease Ugeskrift for Laeger 161(24): 3630
Jost, S.; Lichtlen, P.R. 1995: Modifying increased plasma cholesterol levels in secondary prevention of coronary heart disease Zeitschrift für Kardiologie 84(8): 577-595
Dordević, D.; Jovicić, A.; Regović, V.; Raicević, R. 1998: Increased titer of anticardiolipin antibodies represents the risk for the development of ischemic brain disease in persons below 50 Vojnosanitetski Pregled 55(2 Suppl): 15-21
Bar Dayan, Y.; Amital, H.; Levy, Y.; Shoenfeld, Y. 1996: Low dose aspirin in patients with ischemic heart disease may precipitate secondary myocardial infarction Israel Journal of Medical Sciences 32(5): 288-291
Gryglik, J. 1979: Pharmacological inhibition of platelet aggregation in primary and secondary prevention of ischemic heart disease Polski Tygodnik Lekarski 34(13): 509-511
Khvorostinka, V.N.; Pasieshvili, L.M.; Biazrova, V.V. 1992: The prevalence and secondary prevention of ischemic heart disease and arterial hypertension in workers of the gas recovery industry Likars'ka Sprava 1992(5): 80-82
Polvani, C. 1979: From the Publication 9 to the Publication 26 of the International Commission on Radiological Protection (ICRP) La Medicina del Lavoro 70(6): 494-504
Rabkin, S.W.; Mathewson, A.L.; Tate, R.B. 1978: Predicting risk of ischemic heart disease and cerebrovascular disease from systolic and diastolic blood pressures Annals of Internal Medicine 88(3): 342-345
Ekelund, C.Kvist.; Andersen, H.Jakob.; Christensen, J.; Ersbak, V.; Farlie, R.; Henriques, C.; Holmskov, A.; Jensen, L.Neerup.; Jørgensen, F.Stener.; Hessellund, A.; Larsen, T.; Olesen, A.Wind.; Pedersen, O.Bjørn.; Poulsen, H.; Ramb, J.; Skibsted, L.; Skovbo, P.; Sommer, S.; Sperling, L.; Sundberg, K.; Juul, S.Vemmelund.; Zingenberg, H.; Tabor, A. 2010: Down's syndrome risk assessment in Denmark--secondary publication Ugeskrift for Laeger 172(23): 1759-1761